Education
About Us
Working with TipRanks
Follow Us
Aziyo Biologics (ELUT)
NASDAQ:ELUT
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.17Last Year’s EPS
-1.14Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: -13.57%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a positive outlook with significant achievements such as the successful launch of EluPro, strategic partnerships, and manufacturing expansions. Financial strength was demonstrated despite a decline in Simploderm revenue and litigation-related expenses.Company Guidance
During the Elutia Inc. First Quarter 2025 Financial Results Conference Call, significant guidance was given regarding various metrics. EluPro's first quarter launch was emphasized as a major success with a substantial performance increase, constituting 52% of BioEnvelope revenue, jumping 84% from the fourth quarter, and contributing to a 31% year-over-year growth of $3.1 million for the BioEnvelope division. The company's strategic partnership with Boston Scientific, which boosts their sales force to over 900 reps, was highlighted as a key factor for future growth, with 52 hospitals already engaged. Capacity expansion efforts included a new facility in Gaithersburg, Maryland, to support the production of critical components, aiming to support annual revenues of up to $140 million at 70%+ gross margins. Financially, the company reported a total revenue of $6 million for the quarter, with a 54.8% adjusted gross margin, and a reduction in operating expenses, leading to an adjusted EBITDA of $3.3 million. Cash conservation strategies were also outlined, including amendments with financial partners to support liquidity.Successful Launch of EluPro
EluPro's first full quarter launch exceeded expectations, with an 84% increase from the fourth quarter. It now constitutes 52% of BioEnvelope revenue, driven by approvals from 25 hospitals actively ordering the product.
Partnership with Boston Scientific
The partnership includes 900 sales professionals promoting EluPro, resulting in sales at over 52 hospitals. This collaboration aims to expand market reach and accelerate product adoption.
Manufacturing Expansion
A new facility in Gaithersburg, Maryland, was opened to expand manufacturing capacity for the antibiotic disc, reducing costs and removing supply constraints.
Financial Position Strengthening
The company reported a 31% year-over-year growth in BioEnvelope division revenue, improved sequential growth, and a successful cash position with $17.4 million at quarter's end.
Edison Award and Scientific Recognition
EluPro received an Edison Award for innovation in postsurgical recovery and a peer-reviewed publication confirming its broad-spectrum antibacterial effect.
ELUT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ELUT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $1.99 | $2.08 | +4.52% |
Mar 06, 2025 | $2.55 | $2.78 | +9.02% |
Nov 14, 2024 | $3.83 | $3.56 | -7.05% |
Aug 07, 2024 | $2.84 | $3.07 | +8.10% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Aziyo Biologics (ELUT) report earnings?
Aziyo Biologics (ELUT) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is Aziyo Biologics (ELUT) earnings time?
Aziyo Biologics (ELUT) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ELUT EPS forecast?
ELUT EPS forecast for the fiscal quarter 2025 (Q2) is -0.17.